28,364,865 Danaher Corporation $DHR Shares Sold by State Street Corp

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • State Street cut its Danaher stake by 49.8% in the third quarter, selling 28.36 million shares. It retained 28.55 million shares, worth about $6.34 billion at quarter-end.
  • Danaher reported quarterly earnings of $2.11 per share, beating the $1.92 consensus estimate; revenue rose 8.3% year over year to $6.55 billion, slightly below expectations.
  • Analysts held a “Moderate Buy” consensus rating, with an average price target of $242.91; 18 analysts rated the stock Buy and five rated it Hold.
  • Interested in Danaher? Here are five stocks we like better.

State Street Corp trimmed its stake in Danaher Corporation (NYSE:DHR - Free Report) by 49.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,547,173 shares of the conglomerate's stock after selling 28,364,865 shares during the quarter. State Street Corp owned approximately 4.06% of Danaher worth $6,335,877,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Ilmarinen Mutual Pension Insurance Co lifted its holdings in Danaher by 9.2% in the 3rd quarter. Ilmarinen Mutual Pension Insurance Co now owns 108,700 shares of the conglomerate's stock valued at $24,082,000 after purchasing an additional 9,200 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. grew its holdings in shares of Danaher by 24.6% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 2,658 shares of the conglomerate's stock worth $589,000 after buying an additional 524 shares in the last quarter. Sumitomo Life Insurance Co. grew its holdings in shares of Danaher by 1.2% during the third quarter. Sumitomo Life Insurance Co. now owns 6,670 shares of the conglomerate's stock worth $1,478,000 after buying an additional 80 shares in the last quarter. Whittier Trust Co. grew its holdings in shares of Danaher by 0.8% during the third quarter. Whittier Trust Co. now owns 398,812 shares of the conglomerate's stock worth $87,663,000 after buying an additional 3,327 shares in the last quarter. Finally, TIAA Trust National Association raised its position in shares of Danaher by 81.0% in the third quarter. TIAA Trust National Association now owns 391 shares of the conglomerate's stock valued at $87,000 after buying an additional 175 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

NYSE DHR opened at $220.42 on Friday. The business's 50-day moving average price is $224.82 and its 200 day moving average price is $201.66. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market capitalization of $155.07 billion, a PE ratio of 36.08, a price-to-earnings-growth ratio of 2.89 and a beta of 0.76.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company had revenue of $6.55 billion during the quarter, compared to analysts' expectations of $6.56 billion. During the same quarter in the previous year, the business earned $1.89 EPS. The firm's revenue was up 8.3% on a year-over-year basis. On average, research analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher's dividend payout ratio (DPR) is currently 26.19%.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. Royal Bank Of Canada boosted their price objective on shares of Danaher from $215.00 to $250.00 and gave the company an "outperform" rating in a research report on Monday, October 5th. Guggenheim raised their target price on shares of Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Robert W. Baird lifted their target price on shares of Danaher from $246.00 to $254.00 and gave the stock an "outperform" rating in a research note on Thursday, October 22nd. Citigroup lifted their target price on shares of Danaher from $230.00 to $270.00 and gave the stock a "buy" rating in a research note on Thursday, October 22nd. Finally, Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Monday, October 26th. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $242.91.

Check Out Our Latest Analysis on Danaher

Insider Activity at Danaher

In related news, CAO Christopher Bouda sold 7,598 shares of the company's stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer owned 9,107 shares of the company's stock, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gregory Milosevich sold 2,100 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at approximately $5,158,277.54. This represents a 8.58% decrease in their position. The SEC filing for this sale provides additional information. 10.80% of the stock is currently owned by company insiders.

Danaher Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company's businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines